OTLK
OTLK
NASDAQ · Biotechnology

Outlook Therapeutics Inc

$0.43
+0.04 (+10.10%)
As of Feb 8, 2:22 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 6.04M 5.83M 5.25M
Net Income -1,403,193 -1,267,217 -1,265,078
EPS
Profit Margin -23.2% -21.7% -24.1%
Rev Growth +22.3% +8.5% -2.3%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 14.68M 11.21M 13.12M
Total Equity 15.66M 16.90M 15.49M
D/E Ratio 0.94 0.66 0.85
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -1,857,435 -1,820,131 -1,644,658
Free Cash Flow -1,644,650 -1,133,887 -1,157,439